OncoMatch

OncoMatch/Clinical Trials/NCT06986083

A Study of Changes to Prostate Procedures

Is NCT06986083 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies Local anesthesia for prostate cancer.

Phase 3RecruitingMemorial Sloan Kettering Cancer CenterNCT06986083Data as of May 2026

Treatment: Local anesthesiaThe purpose of this study is to look whether using local anesthesia during a transperineal prostate biopsy, while put to sleep by IV sedation, helps reduce the number of people who feel significant pain in the recovery room. The researchers will also look at how local anesthesia affects the amount of pain medication used, how quickly people can go home after the biopsy, and how well they recover after leaving the hospital.

Check if I qualify

Extracted eligibility criteria

Cancer type

Prostate Cancer

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) · New York, New York

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify